Management of hereditary angioedema: a Canadian approach.
C1 esterase inhibitor (C1-INH) deficiency is a rare disorder that lacks consensus for diagnosis therapy and management. Recognizing that Canada is behind the European approach to this disorder, we have formed the Canadian Hereditary Angioedema Society (CHAES)/Société d'angioédème héréditaire du Canada (SAHC) to foster knowledge of this disorder in Canada and to advance care of patients with this disorder in Canada. We here present a review of treatment of this disorder in Canada including prevention of angioedema events and use of replacement therapy and present an algorithm for diagnosis therapy and management of C1-INH deficiency in Canada for discussion at our International Conference on Hereditary Angioedema to be held in Toronto, Canada, October 24th to 26th, 2003.
Bowen
Tom
T
The Canadian Hereditary, Angioedema Society (CHAES)/ Société d'angioédème héréditaire du Canada, Canada. tbowen@pol.net
Hebert
Jacques
J
Ritchie
Bruce
B
Burnham
Jeanne
J
MacSween
Mike
M
Warrington
Richard
R
Yang
William
W
Issekutz
Andrew
A
Karitsiotis
Nick
N
McCombie
Nancy
N
Giulivi
Tony
T
D000465:Algorithms; D000799:Angioedema / Q000175:diagnosis / Q000628:therapy*; D002170:Canada; D003174:Complement C1 Inactivator Proteins / Q000172:deficiency*; D003226:Congresses as Topic; D017408:Guidelines as Topic; D006801:Humans; D012952:Societies
D003174:Complement C1 Inactivator Proteins